BIOMEDICAL RESEARCH NEWS, AND ARTICLES
mediSKIN products developed using Promed's novel collagen complex enter clinical trials
25 January 2023
We are pleased to announce that the mediSKIN products developed using Promed Bioscience's novel collagen complex, will soon be starting clinical trials at the German Oncology Center, for people who have been diagnosed with breast cancer and head and neck cancer.
This project is funded by the Ίδρυμα Έρευνας και Καινοτομίας/Research and Innovation Foundation through the funding project SEED/0719/0200. The consortium consists of RSL Revolutionary Labs, Promed Bioscience, Theramir Ltd, German Oncology Centre and Cyprus University of Technology. More information on the project can be found on our website at https://lnkd.in/dHMPAKe9